Zobrazeno 1 - 5
of 5
pro vyhledávání: '"April Kendricks"'
Autor:
Kathryn M. Jones, Elise N. Mangin, Corey L. Reynolds, Liliana E. Villanueva, Julio Vladimir Cruz, Leroy Versteeg, Brian Keegan, April Kendricks, Jeroen Pollet, Fabian Gusovsky, Maria Elena Bottazzi, Peter J. Hotez
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
IntroductionChagas disease, caused by chronic infection with the protozoan parasite Trypanosoma cruzi, affects 6-7 million people worldwide. The major clinical manifestation of Chagas disease is chronic Chagasic cardiomyopathy (CCC), which encompasse
Externí odkaz:
https://doaj.org/article/14e07b78bb6a483e8f272051a2aa934e
Autor:
Zongyuan Liu, Rebecca Ulrich, April Kendricks, Kate Wheeler, Ana Carolina Leão, Jeroen Pollet, Maria Elena Bottazzi, Peter Hotez, Fabian Gusovsky, Kathryn Jones, Laura-Isobel McCall
Post-infectious conditions, where clinical symptoms fail to resolve even after pathogen clearance, present major health burdens. However, the mechanisms involved remain poorly understood. In Chagas disease (CD), caused by the parasite Trypanosoma cru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8baf24f6ad203c0c74b9b72e36e2e49c
https://doi.org/10.21203/rs.3.rs-2497474/v1
https://doi.org/10.21203/rs.3.rs-2497474/v1
Autor:
Julio Vladimir Cruz-Chan, Fabian Gusovsky, Liliana Estefanía Villanueva-Lizama, Jeroen Pollet, Kathryn M. Jones, Kristyn Hoffman, Maria Elena Bottazzi, April Kendricks, Leroy Versteeg, Brian Keegan, Peter J. Hotez, Christian Teh-Poot
Publikováno v:
Parasite immunologyREFERENCES. 42(10)
E6020 is a synthetic agonist of Toll-like receptor-4 (TLR4). The purpose of this study was to evaluate the effect of different doses of E6020-SE on Trypanosoma cruzi-specific immune responses and its ability to confer protection against acute lethal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf4f64a635ca40c568c0f39ceb533c42
https://pubmed.ncbi.nlm.nih.gov/32592180
https://pubmed.ncbi.nlm.nih.gov/32592180
Autor:
April Kendricks, Christian R. Abee, Courtney M Sands, Gregory K. Wilkerson, Maria Elena Bottazzi, Suzanne L. Craig, Kathryn M. Jones, Stanton B. Gray, Peter J. Hotez, Bruce J. Bernacky
Publikováno v:
Comp Med
Chagas disease is a zoonotic vector-borne disease caused by infection with the protozoan parasite Trypanosoma cruzi. T. cruzi is found in Latin America and the Southern United States, where it infects many species, including humans and nonhuman prima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8a669e18284f25a491a5550f6985c9a
https://europepmc.org/articles/PMC7137543/
https://europepmc.org/articles/PMC7137543/
Autor:
Brian Keegan, Jeroen Pollet, Leroy Versteeg, Julio Vladimir Cruz-Chan, Peter J. Hotez, Maria Elena Bottazzi, Kathryn M. Jones, Fabian Gusovsky, Ashish Damania, April Kendricks
Publikováno v:
Infection and immunity. 86(4)
Chagas disease affects 6 to 7 million people worldwide, resulting in significant disease burdens and health care costs in countries of endemicity. Chemotherapeutic treatment is restricted to two parasiticidal drugs, benznidazole and nifurtimox. Both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4fcb423f25be452a87df5725b7a24cd
https://pubmed.ncbi.nlm.nih.gov/29311242
https://pubmed.ncbi.nlm.nih.gov/29311242